MENLO PARK, Calif.--(BUSINESS WIRE)--USVP, a top-tier early-stage venture capital firm, today announced the closing of USVP XI, a $300M fund. The new fund continues USVP’s leading franchises in cybersecurity, enterprise software, consumer mobile and e-commerce, and healthcare.
USVP has led early-stage investments in 86 companies that have completed initial public offerings. “In closing USVP XI, we are building on an extensive track record of successful early-stage investing in transformative businesses with massive market potential. Box, Imperva, InsideSales, Intersect ENT, and Trunk Club all have become globally-recognized leaders in their markets,” said Steve Krausz, General Partner. “In the past five years, 24 of our companies have had profitable exits. 6 have attained greater than billion dollar valuations through an IPO or M&A. Our results are not just on paper; in fact, USVP has distributed over one billion dollars to its limited partners during this same five year period. Our team has achieved these results by recognizing promising entrepreneurs early in their careers and investing in companies early in their development. We have been fortunate that many have gone on to become the undisputed leaders in their industries and markets.”
USVP’s strategy is to be the lead Series A investor in companies based in the U.S. or Israel, in four core sectors: cybersecurity, enterprise software, consumer mobile and e-commerce, and healthcare. “USVP is a leader in its areas of focus. USVP has generated a 3X multiple in these sectors since 2008,” remarked Rick Lewis, General Partner. “We continue to innovate within our firm to meet the rapid pace of change in technology.” USVP pioneered venture investing in cybersecurity, and is a recognized leader in this critical technology sector. The firm’s highly-selective Israel strategy has generated a 7X return on invested capital since our first investment in Israel. USVP also is uniquely positioned to capitalize on the emerging IT-enabled healthcare services sector, with proven software and healthcare expertise integrated into a single firm and fund.
The USVP XI investment team is an experienced group of six partners with a track record of 3.3X on realizations across USVP’s three most-recent funds: Steve Krausz, Rick Lewis, Jonathan Root, Casey Tansey, Dafina Toncheva, and Jacques Benkoski. “All of the USVP partners have operating experience and a strong venture investment track record in their investment sectors, and it shows,” said Casey Tansey, General Partner. “In addition to enabling us to attract world-class entrepreneurs, our experience allows the USVP investment professionals to be true company-building partners to our management teams, rather than simply a source of capital. We deeply respect the entrepreneurs we work with, and we are proud and honored to have earned the confidence of the sophisticated limited partners in the U.S. and around the world who have invested in our new fund.”
U.S. Venture Partners (USVP) is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies. USVP has invested in over 400 companies spanning three decades, including: Box, Castlight Health, Check Point Software, Concur, GoPro, Guidewire Software, HotelTonight, Imperva, InsideSales.com, Intersect ENT, Omada Health, OncoMed, SanDisk, Sun Microsystems, Trunk Club, Trusteer, Yammer, and Zerto. USVP focuses on early-stage start-ups that transform cybersecurity, enterprise software, consumer mobile and e-commerce, and healthcare. The USVP team consists of former entrepreneurs, technologists, corporate executives, and financial professionals who assist with strategy, scaling, team building, product development, and business development. USVP is based in Menlo Park, California. More information can be found at www.usvp.com.
